Home
Conditions
Genital Neoplasms, Male

Clinical trial condition

Genital Neoplasms, Male

Explore clinical trials studying Genital Neoplasms, Male. Study availability and eligibility vary by location and protocol.

5,017 public trials 1,024 recruiting studies

Refine in advanced search Browse all conditions

Genital Neoplasms, Male trial results

Completed

A Prostate Cancer Study in Men Undergoing Androgen Deprivation Therapy

NCT00087659

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations: Tucson VA Medical Center Tucson, Arizona, United States

VA Medical Center - Long Beach Long Beach, California, United States

Washington VA Medical Center Washington D.C., District of Columbia, United States

Veterans Affairs Medical Center Augusta, Georgia, United States

View all 16 locations

View Trial Details

Completed

Effects of Octreotide Acetate on Circulating Levels of Chromogranin A in Advanced Prostate Cancer Patients

NCT00166725

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations: Orbassano Orbassano, Italy

View Trial Details

Completed

Exisulind Versus Placebo After Surgical Removal of the Prostate

NCT00166426

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +7 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Evaluation of the Effects of Chemotherapy on the Uptake and Retention of Carbon 11 Methionine in Prostate Cancer Patients

NCT00139204

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Study Evaluating the Correlation Between C-11 Acetate Uptake and Retention as Measured by PET and FAS in Prostate Cancer

NCT00139191

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

An Open-Label, Multi-Center, Phase IIa Trial of PRX302 Treatment of Patients With Locally Recurrent Prostate Cancer After Primary Radiation Therapy

NCT00686088

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations: Urology San Antonio San Antonio, Texas, United States

Scott & White Memorial Hospital Temple, Texas, United States

View Trial Details

Completed

Safety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic Cancer

NCT00541281

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +13 more
Locations: St Pierre Ottignies, Brabant Wallon, Belgium

Notre Dame et Reine Fabiola Charleroi, Hainaut, Belgium

RHMS louis caty Baudour, Belgium

Clinique Saint Luc Bouge, Belgium

View all 19 locations

View Trial Details

Completed

Depiction of Prostate Cancer Treatment Alternatives in Greece

NCT00733213

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +12 more
Locations: Research Site Athens, Greece

Research Site Karditsa, Greece

Research Site Serres, Greece

Research Site Xsanthi, Greece

View Trial Details

Completed

Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

NCT00003391

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations: New York Presbyterian Hospital - Cornell Campus New York, United States

View Trial Details

Completed

Japanese Study of the Combined Administration of Docetaxel With Prednisolone for Metastatic Hormone Refractory Prostate Cancer

NCT00723086

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations: Sanofi-Aventis Administrative Office Tokyo, Japan

View Trial Details

Genital Neoplasms, Male

Genital Neoplasms, Male trial results

Related conditions